Clinical Trials Directory

Trials / Completed

CompletedNCT05713188

Clinical Investigation of the Safety of the MediSieve Magnetic Haemofiltration System in Healthy Volunteers

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
6 (actual)
Sponsor
MediSieve Limited · Industry
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

This is a single-centre, non-randomised, prospective study to assess the safety of the MediSieve blood filtration system in healthy volunteers

Detailed description

The MediSieve Magnetic Haemofiltration System (MMHS) is a system to filter selected moieties from blood in an extracorporeal circuit by magnetic means. Initially, it is developed for the treatment of severe malaria to capture malaria-infected erythrocytes (who are weakly magnetic) to reduce the parasitaemia. However, the use of MMHS can be extended, with the use of antibodies coupled to magnetic beads, to other diseases, such as sepsis. The MMHS has to be used first in healthy volunteers to determine its clinical safety. To this end, 6 healthy male and female volunteers (ratio 1:1) will undergo blood filtration using the MediSieve Magnetic Haemofiltration System (without magnetic beads) for five consecutive hours. Vital signs will be continuously monitored and blood samples will be obtained serially to determine laboratory safety and immunological parameters. Furthermore, volunteers will have two follow up visits at 24 hours and 7 days post filtration.

Conditions

Interventions

TypeNameDescription
DEVICEMediSieve Magnetic Haemofiltration SystemThe MediSieve Magnetic Haemofiltration System is a medical device intended for use in extracorporeal clinical procedures to remove magnetic targets (e.g. malaria infected red blood cells) from a patient's bloodstream. Healthy volunteers will undergo filtration for 5 hours.

Timeline

Start date
2022-06-13
Primary completion
2022-11-17
Completion
2022-11-30
First posted
2023-02-06
Last updated
2023-02-06

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT05713188. Inclusion in this directory is not an endorsement.